- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 353
Anaveon validates Novartis for series A
Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.
Feb 27, 2019PM&HM inhales $4.6m
Russian Academy of Sciences spinout PM&HM has signed up a second government-owned vehicle to help commercialise its digitally-enabled inhaler for tuberculosis, cancer and HIV.
Feb 27, 2019NovaUCD companies bank $864m in 15 years
NovaUCD has helped spawn 45 spinouts since 2003 and offered innovation support to companies which generated more than $128m of combined turnover during 2018.
Feb 26, 2019Fraunhofer looks to get Ahead
Fraunhofer Venture has unveiled an accelerator for businesses based on its research in areas including artificial intelligence, digital medicine and industry 4.0.
Feb 26, 2019Centogene scents IPO
Rare disease diagnosis technology developer Centogene is gearing up for an IPO having spun out from Rostock in 2006 and raised $28.5m of equity funding in 2017.
Feb 25, 2019Corporates champion $113m NordicNinja VC
Honda, Panasonic and Omron are among the limited partners of NordicNinja VC’s inaugural fund, which has identified several university ecosystems in northern Europe as offering opportunities.
Feb 25, 2019Corporates champion $113m NordicNinja VC
Honda, Panasonic and Omron are among the limited partners of NordicNinja VC’s inaugural fund, which will focus on deep tech and help northern European startups expand into Asia.
Feb 25, 2019Ÿnsect breeds $125m series C
Finasucre has taken part in a $125m series C round for Ÿnsect, an agtech developer that breeds insects to use as fish feed and fertiliser.
Feb 25, 2019Corporate venturing deal net: 18-22 February 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Feb 22, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


